Who to call at PHIO PHARMACEUTICALS CORP., and when
Fundz watches for the moments PHIO PHARMACEUTICALS CORP. starts buying, and tells you who to reach.
- An alert the day PHIO PHARMACEUTICALS CORP. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PHIO PHARMACEUTICALS CORP., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PHIO PHARMACEUTICALS CORP.. With Fundz connected, it knows.
PHIO PHARMACEUTICALS CORP.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
phiopharma.comAI Executive Summary
AI-powered analysis of 8-K filing content
Phio Pharmaceuticals held its 2026 Annual Meeting on September 28, 2026, where stockholders approved an amendment to the 2020 Long Term Incentive Plan, increasing available shares by 1.5 million to a total of 2.45 million shares. This strategic move enhances the company's ability to incentivize and retain key personnel.
Key Takeaways
Stockholders approved a 1,500,000 share increase to the 2020 Long Term Incentive Plan, effective immediately
Total shares available under the plan increased from 952,017 to 2,452,017 shares
2 more takeaways
Related Filings (2)
2 more filings from PHIO PHARMACEUTICALS CORP. in the last 90 days
Filing Overview
What This Means
PHIO PHARMACEUTICALS CORP. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.